PulmoBioMed – a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions – has raised £1.4 million to help commercialise its technology.The investment round was led by the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia […]
